Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna
{"title":"新生儿重症监护病房中用于心电图和心率监测的无线皮肤传感器:前瞻性可行性、安全性和准确性研究","authors":"Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna","doi":"10.3389/fbioe.2025.1555882","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.</p><p><strong>Methods: </strong>Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.</p><p><strong>Results: </strong>25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.</p><p><strong>Conclusion: </strong>ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1555882"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069355/pdf/","citationCount":"0","resultStr":"{\"title\":\"Wireless skin sensors for electrocardiogram and heart rate monitoring in the neonatal intensive care unit: a prospective feasibility, safety, and accuracy study.\",\"authors\":\"Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna\",\"doi\":\"10.3389/fbioe.2025.1555882\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.</p><p><strong>Methods: </strong>Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.</p><p><strong>Results: </strong>25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.</p><p><strong>Conclusion: </strong>ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1555882\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069355/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1555882\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1555882","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Wireless skin sensors for electrocardiogram and heart rate monitoring in the neonatal intensive care unit: a prospective feasibility, safety, and accuracy study.
Objectives: Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.
Methods: Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.
Results: 25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.
Conclusion: ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.